Please login to the form below

Not currently logged in
Email:
Password:

DVT

This page shows the latest DVT news and features for those working in and with pharma, biotech and healthcare.

Boston Scientific makes $4.2bn play for UK’s BTG

Boston Scientific makes $4.2bn play for UK’s BTG

vein thrombosis (DVT) and peripheral arterial occlusions.

Latest news

More from news
Approximately 7 fully matching, plus 34 partially matching documents found.

Latest Intelligence

  • The rise of chronic disease in BRIC markets The rise of chronic disease in BRIC markets

    Cardiovascular diseases – such as heart attack, stroke, DVT and atrial fibrillation – also present a major problem in Russia, with 46 per cent of self-reported sufferers (39 per cent being diagnosed).

  • Modern anticoagulants threaten status quo Modern anticoagulants threaten status quo

    Certoparin sodium has been launched for the treatment of DVT and is in phase III trials for prevention of thrombosis in medically ill patients.

  • Go with the flow

    Find out if you are at risk of developing DVT in hospital by asking for a risk assessment.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics